Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (3): 109-114.doi: 10.6040/j.issn.1671-7554.0.2019.014
ZHANG Lu, XU Minxuan, YANG Xiaoxue, JIA Liying
CLC Number:
[1] 马海燕, 郎颖, 黄娟, 等. 取消药品加成对城市公立医院运营影响及实际补偿率预测研究[J]. 中国医院管理, 2018, 38(12):7-10. MA Haiyan, LANG Ying, HUANG Juan, et al. Study on influences of canceling drug addition policy on operation of urban public hospitals and prediction of its actual compensation ratio[J]. Chinese Hospital Management, 2018, 38(12):7-10. [2] 庞晓燕, 刘俊峰, 褚湜婧, 等. 关于进一步完善公立医院补偿机制的建议[J]. 中国卫生经济, 2018, 37(3):18-20. PANG Xiaoyan, LIU Junfeng, CHU Shijing, et al. Suggestion on further improvement of the compensation mechanism in public hospitals[J]. Chinese Health Economics, 2018, 37(3):18-20. [3] 董盼盼, 窦蕾, 屈晓远, 等. 公立医院补偿机制改革宏观影响因素的政策情景分析[J]. 中国医院管理, 2018, 38(1):11-13. DONG Panpan, DOU Lei, QU Xiaoyuan, et al. Policy scenarios analysis based on macroscopic influencing factors affecting the compensation mechanism of public hospitals[J]. Chinese Hospital Management, 2018, 38(1):11-13. [4] 马爱霞, 陆忆娟, 谢静, 等. 不同类型公立医院医药价格综合改革的补偿效果评价[J]. 中国医院管理, 2018, 38(4):12-14. MA Aixia, LU Yijuan, XIE Jing, et al. Evaluation of compensation of different kinds of public hospitals in pharmaceutical pricing reform[J]. Chinese Hospital Management, 2018, 38(4):12-14. [5] James CD, Peabody J, Hanson K, et al. Public hospital care:Equal for all or equal for some? Evidence from the Philippines[J]. Asia Pac J Public Health, 2015, 27(2):1026-1038. [6] de Marco A, Mangano G, Corinna Cagliano A, et al. Public financing into build-operate-transfer hospital projects in Italy[J]. J Constr Eng Manage, 2012, 138(11):1294-1302. [7] Hellowell M. PFI redux? Assessing a new model for financing hospitals[J]. Health Policy, 2013, 113(1/2):77-85. [8] Joynt KE, Le ST, Orav EJ, et al. Compensation of chief executive officers at nonprofit US hospitals[J]. JAMA Intern Med, 2014, 174(1):61-67. [9] Reiter KL, Sandoval GA, Brown AD, et al. CEO compensation and hospital financial performance[J]. Med Care Res Rev, 2009, 66(6):725-738. [10] 何小群, 张亮.县级公立医院综合改革前后收支结构变动情况分析[J]. 中国卫生经济, 2018, 37(9):33-36. HE Xiaoqun, ZHANG Liang. Analysis on the revenue and expenditure structure change of county-level hospitals before and after the comprehensive reform of county-level public hospitals[J]. Chinese Health Economics, 2018, 37(9):33-36. [11] 张晓星, 蒋淑敏, 李媛菊, 等. 郑州市县级公立医院门诊收入结构变动分析[J]. 中国医院管理, 2018, 38(6):55-57. ZHANG Xiaoxing, JIANG Shumin, LI Yuanju, et al. Analysis of the change of outpatient income structure variation of country-level public hospitals[J]. Chinese Hospital Management, 2018, 38(6):55-57. [12] 闫娟娟, 王萍, 胡安霞. 2010—2016年山西省县级公立医院收支结构分析[J]. 中国卫生经济, 2018, 37(6):29-32. YAN Juanjuan, WANG Ping, HU Anxia. Analysis on the revenue and expenditure structure of county public hospitals in Shanxi from 2010 to 2016[J]. Chinese Health Economics, 2018, 37(6):29-32. [13] 江景华, 尹龙祥, 吴筱. 从财务收支分析看县级公立医院综合改革[J]. 卫生经济研究, 2017(11):39-41. [14] 朱晓强, 马晓峰, 张华, 等. 药品零加成背景下县级公立医院运行效率分析:基于DEA-malmquist指数分析法[J]. 中国卫生事业管理, 2017, 34(10):757-760. ZHU Xiaoqiang, MA Xiaofeng, ZHANG Hua, et al. Analyzing the operation efficiency of county public hospitals under the background of zero price addition policy of drugs based on DEA-malmquist exponential analysis[J]. Chinese Health Service Management, 2017, 34(10):757-760. [15] Linden A. Conducting interrupted time-series analysis for single- and multiple-group comparisons[J]. The Stata Journal, 2015, 15(2):480-500. [16] Wagner AK, Soumerai SB, Zhang F, et al. Segmented regression analysis of interrupted time series studies in medication use research[J]. J Clin Pharm Ther, 2002, 27(4):299-309. [17] Chun SY, Park HK, Han KT, et al. Deregulation of sale of over-the-counter drugs outside of pharmacies in the Republic of Korea:interrupted-time-series analysis of outpatient visits before and after the policy[J]. BMC Health Serv Res, 2017, 17(1):478. [18] Fretheim A, Håvelsrud K, MacLennan G, et al. The effects of mandatory prescribing of thiazides for newly treated, uncomplicated hypertension:interrupted time-series analysis[J]. PLoS Med, 2007, 4(7):e232. doi:10.1371/journal.pmed.0040232. [19] 李小菊, 毛璐, 张梅, 等. 总额预付制改革对职工医保患者住院服务的影响分析[J]. 卫生经济研究, 2018(11):46-49. LI Xiaoju, MAO Lu, ZHANG Mei, et al. Analysis of the influence of the total prepayment system reform on the hospitalization of employee medical insurance patients[J]. Health Economics Research, 2018(11):46-49. [20] 冷家骅, 刘忆, 陈治水, 等. 北京市医药分开综合改革对肿瘤专科医院的影响:基于北京某肿瘤医院医保数据的实证分析[J].中国卫生政策研究, 2017, 10(12):15-21. LENG Jiahua, LIU Yi, CHEN Zhishui, et al. Impact of separating drug sales from medical services reform on Beijing Cancer Hospital from the perspective of medical insurance data[J]. Chinese Journal of Health Policy, 2017, 10(12):15-21. [21] 张敏, 赵琨, 李雪, 等. 青岛市某医院临床路径改革对医疗费用影响的ITS分析[J]. 中国卫生经济, 2016, 35(2):67-68. ZHANG Min, ZHAO Kun, LI Xue, et al. Interrupted time series analysis on clinical pathway reform's effect on hospitalization costs in a hospital of Qingdao[J]. Chinese Health Economics, 2016, 35(2):67-68. [22] 田侃, 戈志强, 陈彦瑾, 等. 临床路径对短暂性脑缺血患者影响的ITS分析[J]. 中国医院管理, 2017, 37(6):41-43. TIAN Kan, GE Zhiqiang, CHEN Yanjin, et al. ITS analysis of the effect of clinical pathway reform on transient ischemic attack patients[J]. Chinese Hospital Management, 2017, 37(6):41-43. [23] 朱星月, 林腾飞, 米源, 等. 间断时间序列模型及其在卫生政策干预效果评价中的应用[J].中国药事, 2018, 32(11):1531-1540. ZHU Xingyue, LIN Tengfei, Mi Yuan, et al. Interrupted time series model and its application in effect evaluation of health policy intervention[J]. Chinese Pharmaceutical Affairs, 2018, 32(11):1531-1540. [24] 王飞, 汤少梁, 赵琨, 等. 应用间断时间序列评价某县级公立医院医药价格改革效果[J].中国卫生统计, 2016, 33(1):78-80. [25] 许敏旋. 城市公立医院补偿机制改革对医院经济运行的影响[D].济南:山东大学, 2018. [26] 吴晶晶, 陈志仙, 张昕男, 等. 江苏省公立医院综合改革效果评价研究:基于间断时间序列分析[J].中国卫生事业管理, 2018, 35(3):163-166. WU Jingjing, CHEN Zhixian, ZHANG Xinnan, et al. Evaluating the effect of comprehensive reform on public hospitals in Jiangsu province based on intermittent time series analysis[J]. Chinese Health Service Management, 2018, 35(3):163-166. [27] 唐文熙, 夏海鸣, 刘奇志, 等. 南京市属公立医院医药价格综合改革补偿效果评价[J]. 中国卫生政策研究, 2017, 10(12):1-8. TANG Wenxi, XIA Haiming, LIU Qizhi, et al. Effect evaluation of comprehensive reform of medical price in urban public hospital:A case study of Nanjing city[J]. Chinese Journal of Health Policy, 2017, 10(12):1-8. [28] 方福祥. 基于取消药品加成的医疗服务价格调整实践探索[J].卫生经济研究, 2018(7):27-30. FANG Fuxiang. Practice exploration of adjusting medical service price based on canceling drug addition[J]. Health Economics Research, 2018(7):27-30. [29] 赵宏, 杨立嵘, 赵磊, 等. 青海省医疗服务价格改革对公立医院收入影响研究[J]. 中国医院管理, 2018, 38(10):7-8. ZHAO Hong, YANG Lirong, ZHAO Lei, et al. Research on impact of medical service price reform on the income of public hospital in Qinghai Province[J]. Chinese Hospital Management, 2018, 38(10):7-8. [30] 闻庆柱, 刘倩, 高文凤, 等. 取消药品加成公立医院收支状况及医疗费用变化分析[J]. 中国医院管理, 2018, 38(8):4-7. WEN Qingzhu, LIU Qian, GAO Wenfeng, et al. Analysis of the changes of public hospital revenue and expenditure and medical expenditure after canceling drug price addition[J]. Chinese Hospital Management, 2018, 38(8):4-7. [31] 高楠, 徐伟, 江欣禅. 公立医院医疗服务价格水平的对比研究[J].卫生经济研究, 2018(4):7-9. GAO Nan, XU Wei, JIANG Xinshan. A comparative study on the price level of medical services in public hospitals[J]. Health Economics Research, 2018(4):7-9. [32] 陈丹妮, 顾建钧, 王兰钧, 等. 医药价格调整政策对公立医院经济运行影响研究[J].中国医院管理, 2018, 38(9):59-61. CHEN Danni, GU Jianjun, WANG Lanjun, et al. Study on the influence of medical price reform on the economic operation in public hospitals[J]. Chinese Hospital Management, 2018, 38(9):59-61. [33] 张晓溪, 王海银, 周佳卉, 等. 2014—2016年上海市公立医院经济运行状况分析[J].中国卫生资源, 2018, 21(6):491-495. ZHANG Xiaoxi, WANG Haiyin, ZHOU Jiahui, et al. Analysis on operating economical status of public hospitals in Shanghai from 2014 to 2016[J]. Chinese Health Resources, 2018, 21(6):491-495. |
[1] | JIANG Xiaofeng, YAO Jingjing, ZHU Dawei, HE Ping, SHI Xuefeng, MENG Qingyue. Influence of compensation mechanism reform on the hospitalization expenses of a county-level public hospital in Shandong Province [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 95-102. |
|